Biomarker (or Genomic Diagnostic) testing is key in today’s world of precision medicine. Lung cancer biomarker testing is also known as tumor testing, genetic mutation testing, next generation sequencing (NGS) or genomic testing. It looks for changes in the
...
Understanding Your Lung Cancer Diagnosis Life after a lung cancer diagnosis may feel like a blur. Some patients express feeling bombarded with so much information that they aren’t sure where or how to start navigating through the meaning and
...
Imagine a doctor saying: “You have lung cancer.” What do you do? Who do you talk to? How do you comprehend the complicated new language of cancer? Lung Cancer Foundation of America has stepped in to help with two…
KRAS-positive lung cancer, refers to any lung cancer that tests positive for a KRAS biomarker. The KRAS biomarker is present in approximately 15-25% of patients with non-small cell lung cancer (NSCLC). The KRAS biomarker belongs to a class of
...
A ROS1-positive lung cancer, also known as a ROS1 rearrangement in lung cancer, refers to any lung cancer that tests positive for a fusion in the ROS1 gene. ROS1 rearrangements occur in approximately 1-2% of patients with non-small cell
...
EGFR stands for epidermal growth factor receptor. EGFR is a protein expressed on the surface of cells. It is most commonly found on cells on the skin, although it can be found elsewhere in the body. An EGFR mutation
...
ALK positive (anaplastic lymphoma kinase positive, or ALK+) lung cancer occurs in 1 out of 25 non-small-cell lung cancer patients (NSCLC — the most common type of lung cancer). Younger patients — usually 55 and under — who have
...